Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 09 Sept 2026 for Agilent Technologies, INC., €83k. Read the official filing
Filing timeline
BuySaleMikael Dolsten
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mikael Dolsten: trading record in brief
Mikael Dolsten (chief executive) discloses dealings in 4 companies, chiefly Pfizer Inc, Agilent Technologies, Inc. and Rocket Pharmaceuticals, Inc. We count 25 filings; the first trade dates from 22 September 2021 and the latest from 4 September 2026.
Every open-market trade on record is a sale: 4 sales worth €614k. The rest of the record consists of 15 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
Most recently, on 9 September 2026, the filings show an open-market sale worth €83k in Agilent Technologies, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mikael Dolsten
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
634 shares@ US$151.375Common StockSEC:0001090872-26-000065:0
22,862 shares0Common StockSEC:0001140361-26-027679:0
1,600 shares@ US$135.420.0005% mcap15.3% of flowCommon StockSEC:0001090872-26-000057:0
14,312 sharesCommon StockSEC:0001193125-26-224624:0
2,158 shares@ US$111.7515.6% of flowCommon StockSEC:0001090872-26-000027:0
14,312 shares0Common StockSEC:0001492422-26-000092:0
2,600 shares@ US$149.81220.0% of flowCommon StockSEC:0001090872-25-000083:0
30,000 shares0Common StockSEC:0001140361-25-026409:0
14,220 shares0Common StockSEC:0001140361-25-015425:0
1,819 shares@ US$121.1816.6% of flowCommon StockSEC:0001127602-25-009721:0
1,678 shares@ US$147.4818.6% of flowCommon StockSEC:0001127602-24-010682:0
21,437 shares@ US$27.043.3% of flowCommon StockSEC:0001225208-24-003244:0
24,822 shares@ US$27.763.9% of flowCommon StockSEC:0001225208-24-003051:0
1,658 shares@ US$136.8217.6% of flowCommon StockSEC:0000899243-23-009221:0
37,078 shares@ US$41.758.9% of flowCommon StockSEC:0001225208-23-002917:0
32,592 shares@ US$42.387.9% of flowCommon StockSEC:0001225208-23-002811:0
50,938 shares@ US$30.179.5% of flowCommon StockSEC:0001225208-22-011483:0
200 shares@ US$49.360.1% of flowCommon StockSEC:0001225208-22-006909:0
1,785 shares@ US$136.8213.2% of flowCommon StockSEC:0001127602-22-010048:0
62,022 shares@ US$27.3411.8% of flowCommon StockSEC:0001225208-22-004229:0
29,744 shares@ US$47.729.8% of flowCommon StockSEC:0001225208-22-003662:0
29,767 shares@ US$46.879.5% of flowCommon StockSEC:0001225208-22-003473:0
71,187 shares@ US$30.1714.7% of flowCommon StockSEC:0001225208-21-015184:0
76,135 shares@ US$22.8911.7% of flowCommon StockSEC:0001225208-21-013883:0
567 shares@ US$172.445.0% of flowCommon StockSEC:0001127602-21-025723:0
25 of 25 declarations
